Maravai LifeSciences (MRVI) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Co-Founder & Executive Chairman of Maravai LifeSciences Holdings Carl Hull Buys 174% More Shares
Simply Wall StNov 16 08:02 ET
Maravai LifeSciences Initiated at Peer Perform by Wolfe Research
Dow JonesNov 14 08:52 ET · Ratings
Maravai LifeSciences Analyst Ratings
BenzingaNov 14 08:40 ET · Ratings
Wolfe Research Initiates Maravai LifeSciences(MRVI.US) With Hold Rating
Moomoo NewsNov 14 07:31 ET · Ratings
Estimating The Fair Value Of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Simply Wall StNov 13 08:15 ET
Maravai LifeSciences | 10-Q: Q3 2024 Earnings Report
SECNov 12 17:29 ET · Announcements

Comments

Stock_Drift

Sep 24 07:16

$Maravai LifeSciences (MRVI.US)$

Moomoo AI

Apr 6 09:07

Despite Maravai LifeSciences Holdings' significant liabilities, it has net cash, indicating a light debt load. However, its pre-interest and tax loss and declining revenue raise future earnings and balance sheet health concerns.

Is Maravai LifeSciences Holdings (NASDAQ:MRVI) Using Debt In A Risky Way?

1

Moomoo AI

Dec 21, 2023 06:11

While Maravai LifeSciences Holdings displays a low ROE, its ability to expand net income considerably due to efficient management and high profit reinvestment is a positive sign. Current analyst forecasts suggest continued earnings growth for the company.

Declining Stock and Decent Financials: Is The Market Wrong About Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)?

Moomoo AI

Dec 21, 2023 06:02

While Maravai LifeSciences Holdings displays a low ROE, its ability to expand net income considerably due to efficient management and high profit reinvestment is a positive sign. Current analyst forecasts suggest continued earnings growth for the company.

Declining Stock and Decent Financials: Is The Market Wrong About Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)?

Moomoo AI

Dec 21, 2023 05:43

While Maravai LifeSciences Holdings displays a low ROE, its ability to expand net income considerably due to efficient management and high profit reinvestment is a positive sign. Current analyst forecasts suggest continued earnings growth for the company.

Declining Stock and Decent Financials: Is The Market Wrong About Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)?

MRVI Maravai LifeSciences

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target